The ENT Reimbursement Landscape
The procedure hasn't changed. Where it's performed — and how it's paid — has.
In otolaryngology, the same clinical work can be worth dramatically different amounts depending on site of service, the ancillary lines around it, and the contract behind the implant.
Sinus, airway, and ear procedures have migrated out of the hospital: balloon sinuplasty, nasal endoscopy, laryngoscopy, and in-office tympanostomy are now routinely performed in the office, while higher-acuity cases shift to the ambulatory surgery center. Each move changes the facility fee, the professional split, and the payer's medical-necessity posture — and payers have responded with intensifying prior-authorization and documentation scrutiny on sinus and sleep procedures.
Around the procedural core sit revenue lines that behave nothing like it: audiology and hearing-aid dispensing remain largely cash and limited-coverage DME — now disrupted by OTC hearing aids — while integrated allergy testing and immunotherapy, head & neck oncology, and sleep and airway work such as hypoglossal nerve stimulation carry high-cost implants and complex authorization. As PE- and MSO-backed platforms consolidate ENT and allergy, the same practice can be worth far more depending on how each of these streams is contracted, sited, and defended — and that is precisely where Fulcrum works.
Illustrative composition. Replace with your confirmed figures before launch; reflects current CMS site-of-service, ASC, and public payer methodology, 2024–2026.
